Description
An α ;-glucosidase inhibitor which induces an enhanced and prolonged release of glucagon-like peptide-1, regulating appetite and stabilizing body weight in humans. Displays anti-atherothrombotic effect by reducing platelet activation and raising circulating adiponectin levels in patients with type 2 diabetes. Clinically useful antidiabetic agent.
Appearance
Pale yelow solid
Product Overview
An α-glucosidase inhibitor
Molecular Formula
C 8 H 17 NO 5
Chemical Name
(2R,3R,4R,5S)-1-(2-Hydroxyethyl)-2-(-(hydroxymethyl)piperidine-3,4,5-triol; N-(2-Hydroxyethyl)-1-deoxynojirimycin
Shipping Conditions
Gel pack
Download Datasheet